Key result
Serbian Clinical Frailty Scale shows excellent inter-rater and test-retest reliability.
Why the study?
The Clinical Frailty Scale is widely recommended to predict adverse postoperative outcomes, but it had never been validated in Serbia.
Is the Serbian version of the Clinical Frailty Scale a valid and reliable tool for assessing frailty in patients undergoing major uro-oncological surgery?
Cross-Sectional (n=149)
Is the Serbian version of the Clinical Frailty Scale a valid and reliable tool for assessing frailty in patients undergoing major uro-oncological surgery?
The Serbian version of the Clinical Frailty Scale is a reliable and valid tool for preoperative frailty assessment in older patients undergoing major uro-oncological surgery.
Answers are grounded in this paper and cite their sources.
May support preoperative frailty screening with Serbian CFS; leaves open whether it improves surgical outcomes.
Background/Objectives: Frailty is well-recognized as a predictor of adverse postoperative outcomes. The Clinical Frailty Scale (CFS) is a widely recommended frailty assessment tool due to its simplicity and rapid bedside applicability; however, it has never been validated in Serbia. The aim of this study was to translate, culturally adapt, and validate the CFS in Serbia, in patients undergoing elective major surgical procedures. Methods: This cross-sectional study included 149 patients aged ≥50 years undergoing elective major urological oncology surgery. Frailty was assessed preoperatively using three scales: the CFS, the Edmonton Frail Scale (EFS), and the FRAIL scale. The CFS evaluations were independently performed by two raters and repeated after 7 days. Concurrent validity was evaluated via Spearman’s correlation between the CFS, the EFS, and the FRAIL scale. The “known-group” construct validity of the CFS was assessed using the test for trends across clinically relevant groups. Both inter-rater and test–retest reliability were assessed using the intraclass correlation coefficient (ICC). Results: The CFS was translated and culturally adapted into the Serbian language in accordance with ISPOR guidelines. The Serbian version of the CFS demonstrated both excellent inter-rater reliability (ICC = 0.957; 95% CI 0.941–0.968), and test–retest reliability (ICC = 0.958; 95% CI 0.943–0.970). A strong positive correlation was observed between the CFS and both the EFS (ρ = 0.698) and the FRAIL scale (ρ = 0.614). A known-group comparison confirmed the construct validity of the CFS. Conclusions: The Serbian version of the CFS is a reliable, valid, and clinically feasible tool for preoperative identification of frailty in patients aged 50 years and older undergoing major elective uro-oncological procedures.
No takes yet. Share an insight, caveat, or question.
Petrović et al. (2026) conducted a cross-sectional in Elective major urological oncology surgery (n=149). Serbian version of the Clinical Frailty Scale (CFS) vs. Edmonton Frail Scale (EFS) and FRAIL scale was evaluated on Inter-rater reliability (ICC 0.957, 95% CI 0.941-0.968). The Serbian version of the Clinical Frailty Scale demonstrated excellent inter-rater reliability (ICC 0.957; 95% CI 0.941-0.968) and test-retest reliability (ICC 0.958; 95% CI 0.943-0.970).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: